Pre-release: this release has not been published. Identifiers are permanent; descriptions may still change.
37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications.
37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications., “Language, paper, writing, margins, read-only optical disc specifications”, is a CFR section of 37 CFR Part 1, Subpart B, Subject Group: The Application—The Application; in force.
https://ontology.bommaritollc.com/id/01a0f0a7-95b1-76dc-9566-e3d5917c6ea6
Elsewhere
Facts
| adms:identifier | |
| eli:cites | |
| prov:wasDerivedFrom | |
| schema:isPartOf | |
| schema:legislationIdentifier | 37 CFR 1.52 |
| schema:legislationJurisdiction | |
| schema:legislationLegalForce | |
| schema:legislationType | |
| schema:name | Language, paper, writing, margins, read-only optical disc specificationsen |
| schema:url | |
| skos:prefLabel | 37 CFR 1.52 Language, paper, writing, margins, read-only optical disc specifications.en |
Related
Cited by (22)eli:cites
- 37 CFR 1.121 Manner of making amendments in applications.
- 37 CFR 1.17 Patent application and reexamination processing fees.
- 37 CFR 1.173 Reissue specification, drawings, and amendments.
- 37 CFR 1.20 Post-issuance fees.
- 37 CFR 1.211 Publication of applications.
- 37 CFR 1.217 Publication of a redacted copy of an application.
- 37 CFR 1.530 Statement by patent owner in ex parte reexamination; amendment by patent owner in ex parte or inter partes reexamination; inventorship change in ex parte or inter partes reexamination.
- 37 CFR 1.58 Chemical and mathematical formulae and tables.
- 37 CFR 1.615 Format of papers filed in a supplemental examination proceeding.
- 37 CFR 1.704 Reduction of period of adjustment of patent term.
- 37 CFR 1.77 Arrangement of application elements.
- 37 CFR 1.821 Nucleotide and/or amino acid sequence disclosures in patent applications.
- 37 CFR 1.823 Requirements for content of a “Sequence Listing” part of the specification.
- 37 CFR 1.824 Form and format for a nucleotide and/or amino acid sequence submission as an ASCII plain text file.
- 37 CFR 1.825 Amendment to add or replace a “Sequence Listing” and CRF copy thereof.
- 37 CFR 1.833 Requirements for a “Sequence Listing XML” for nucleotide and/or amino acid sequences as part of a patent application filed on or after July 1, 2022.
- 37 CFR 1.834 Form and format for nucleotide and/or amino acid sequence submissions as the “Sequence Listing XML” in patent applications filed on or after July 1, 2022.
- 37 CFR 1.835 Amendment to add or replace a “Sequence Listing XML” in patent applications filed on or after July 1, 2022.
- 37 CFR 1.91 Models or exhibits not generally admitted as part of application or patent.
- 37 CFR 1.94 Return of models, exhibits or specimens.
- 37 CFR 1.943 Requirements of responses, written comments, and briefs in inter partes reexamination.
- 37 CFR 1.96 Submission of computer program listings.